HSP60 (Heat Shock Protein 60)
<table class="infobox infobox-protein">
<tr>
<th class="infobox-header" colspan="2">HSP60 (Heat Shock Protein 60)</th>
</tr>
<tr>
<td class="label">Symbol</td>
<td><strong>HSP60</strong></td>
</tr>
<tr>
<td class="label">Full Name</td>
<td>HSP60 (Heat Shock 60)</td>
</tr>
<tr>
<td class="label">Type</td>
<td>Protein</td>
</tr>
<tr>
<td class="label">UniProt</td>
<td><a href="https://www.uniprot.org/uniprot/?query=HSP60" target="_blank">Search UniProt</a></td>
</tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/aging" style="color:#ef9a9a">Aging</a>, <a href="/wiki/alzheimer" style="color:#ef9a9a">Alzheimer</a>, <a href="/wiki/cancer" style="color:#ef9a9a">Cancer</a>, <a href="/wiki/cardiovascular" style="color:#ef9a9a">Cardiovascular</a>, <a href="/wiki/lymphoma" style="color:#ef9a9a">Lymphoma</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">93 edges</a></td>
</tr>
</table>
Overview
Mermaid diagram (expand to render)
HSP60 (Heat Shock Protein 60), also known as HspD1 or Cpn60, is a mitochondrial chaperonin protein essential for proper protein folding within the mitochondrion. Encoded by the [HSPD1 gene](/genes/hspd1), Hsp60 forms a barrel-like complex that provides an isolated environment for folding of over 200 mitochondrial proteins [@ran2014]. This protein plays a critical role in maintaining mitochondrial proteostasis, and its dysfunction has been strongly implicated in neurodegenerative diseases including [Alzheimer's disease](/diseases/alzheimers-disease), [Parkinson's disease](/diseases/parkinsons-disease), and [amyotrophic lateral sclerosis](/diseases/als) [@soleimanpour2014].
Hsp60 functions as part of a larger [molecular chaperone network](/mechanisms/molecular-chaperones) that includes Hsp10 (co-chaperone), Hsp70, and Hsp90. The chaperonin complex creates a protected folding chamber that prevents protein aggregation during the complex process of mitochondrial protein maturation. Given the central role of mitochondria in neuronal energy metabolism and [apoptosis](/mechanisms/apoptosis) regulation, Hsp60 represents a critical therapeutic target for neurodegenerative conditions [@hansen2007].
Structure and Molecular Architecture
Hsp60 exhibits a distinctive heptameric barrel structure, forming a large chamber that serves as the folding cage for client proteins:
- Heptameric ring: Seven Hsp60 subunits arrange in a ring-like structure, each approximately 60 kDa
- Double-barrel architecture: The complex forms two stacked heptameric rings, creating a barrel-shaped chamber approximately 25 nm in diameter
- ATP-binding domains: Each subunit contains an ATP-binding pocket in the equatorial domain, required for the conformational changes that drive the folding cycle
- Flexible apical domains: The apical domains form the entrance to the folding chamber and interact with client proteins and co-chaperones
The folding cycle involves ATP-dependent conformational changes that allow client protein entry, encapsulation, folding, and release. Hsp10 (GroES homolog) forms a "lid" on the chamber, creating the complete folding environment [@cheng2020].
- Hsp60 (HSPD1): The primary mitochondrial isoform, constitutively expressed
- Hsp60 variant: Alternative splicing generates neuronal-specific isoforms
- HSPD2: A related protein expressed in testis and some peripheral tissues
- HSPE1: The Hsp10 co-chaperone that works with Hsp60
Biological Functions
Mitochondrial Protein Folding
The primary function of Hsp60 is facilitating proper folding of mitochondrial proteins:
Protein import: Mitochondrial proteins synthesized in the cytosol contain targeting signals that direct them to the organelle
Translocation: Proteins translocate across the inner mitochondrial membrane via the TIM complex
Folding: Unfolded proteins enter the Hsp60 chamber and fold in the protected environment
Release: ATP hydrolysis triggers conformational changes that release properly folded proteinsHsp60 specifically assists folding of proteins that cannot achieve proper conformation spontaneously, including components of the [electron transport chain](/mechanisms/mitochondrial-dysfunction), [mitochondrial quality control](/mechanisms/mitochondrial-quality-control-network-pathway) proteins, and metabolic enzymes [@kelley2019].
Complex Assembly
Beyond individual protein folding, Hsp60 assists assembly of multi-subunit complexes:
- Complex I (NADH dehydrogenase): Assembly of the 45-subunit complex I requires Hsp60-mediated folding of multiple components
- Complex V (ATP synthase): Folding of ATP synthase subunits depends on Hsp60
- Mitochondrial metabolic enzymes: Pyruvate dehydrogenase and other multi-enzyme complexes require Hsp60 assistance
Apoptosis Regulation
Hsp60 plays a dual role in [apoptosis regulation](/mechanisms/apoptosis):
- Pro-survival: Proper Hsp60 function maintains mitochondrial integrity and prevents release of pro-apoptotic factors like cytochrome c
- Anti-apoptotic interactions: Hsp60 can bind and sequester pro-apoptotic proteins like Bax and Bak
- Dysregulation leads to cell death: Loss of Hsp60 function can trigger mitochondrial apoptosis pathways
Role in Neurodegenerative Diseases
Alzheimer's Disease
Hsp60 dysfunction contributes to multiple aspects of [Alzheimer's disease pathogenesis](/diseases/alzheimers-disease):
Mitochondrial proteostasis failure: Reduced Hsp60 levels impair folding of mitochondrial proteins, leading to mitochondrial dysfunction
Tau pathology: Hsp60 can bind to hyperphosphorylated tau, and its dysfunction may exacerbate tau aggregation
Amyloid effects: Amyloid-beta can directly impair mitochondrial function, and Hsp60 response is insufficient to compensate
Energy failure: Loss of complex I and IV activity in AD brain correlates with Hsp60 dysfunctionStudies have documented reduced Hsp60 expression in AD hippocampus and cortex, with the most severe deficits in regions most affected by neurodegeneration [@wang2021].
Parkinson's Disease
In [Parkinson's disease](/diseases/parkinsons-disease), Hsp60 connects to several key pathogenic mechanisms:
PINK1/Parkin pathway: Hsp60 interacts with the [PINK1/Parkin mitophagy](/mechanisms/parkin-mediated-mitophagy) pathway; loss of Hsp60 function impairs mitochondrial quality control
Complex I deficiency: Parkinson's disease brains show specific complex I dysfunction that involves Hsp60-dependent assembly
Alpha-synuclein interaction: Hsp60 can bind to alpha-synuclein and may influence its aggregation
Dopaminergic neuron vulnerability: The high energy demands of dopaminergic neurons make them particularly dependent on Hsp60 functionHsp60 modulators are being explored as neuroprotective agents for PD [@zhang2022].
Amyotrophic Lateral Sclerosis
Hsp60 dysfunction is implicated in [ALS](/diseases/als) through multiple mechanisms:
Mitochondrial protein aggregation: ALS-linked proteins including TDP-43 and FUS can form aggregates that overwhelm Hsp60 capacity
SOD1 mutations: Mutations in superoxide dismutase 1 (SOD1) that cause familial ALS require Hsp60 for proper folding
Axonal transport: Mitochondrial dysfunction from Hsp60 deficiency impairs axonal transport in motor neurons
Hereditary spastic paraplegia: HSPD1 mutations cause SPG13, a hereditary spastic paraplegia with features overlapping with ALSOther Neurodegenerative Conditions
- Huntington's disease: Hsp60 dysfunction contributes to mitochondrial deficits in HD
- Friedreich's ataxia: Frataxin deficiency affects Hsp60-dependent iron-sulfur cluster assembly
- Spastic paraplegia: HSPD1 mutations cause hereditary spastic paraplegia type 13 (SPG13)
Therapeutic Implications
Hsp60-Targeted Therapeutics
Given the central role of Hsp60 in mitochondrial proteostasis, several therapeutic strategies are being explored:
Small molecule chaperone activators
- Compounds that enhance Hsp60 ATPase activity and folding efficiency
- Mitochondrial-targeted small molecules that increase Hsp60 expression
- Examples: Geranylgeranylacetone, BGP-15
Protein-protein interaction modulators
- Agents that enhance Hsp60-Hsp10 interaction
- Stabilizers of the Hsp60-client protein complex
Gene therapy approaches
- Viral delivery of HSPD1 under neuronal promoters
- Mitochondrial-targeted gene therapy constructs
- CRISPR-based approaches for correcting SPG13 mutations
Combination Strategies
Hsp60-targeted therapies may be combined with:
- [Antioxidants](/mechanisms/oxidative-stress) to address mitochondrial oxidative stress
- Mitochondrial biogenesis agents (PGC-1alpha activators)
- [Autophagy](/mechanisms/autophagy) enhancers to clear damaged mitochondria
- Metabolic supporters (coenzyme Q10, creatine)
Protein Interactions
Hsp60 interacts with numerous proteins in the mitochondrial proteostasis network:
Co-chaperones
- [HSPE1](/genes/hspe1) (Hsp10): Co-chaperone that forms the lid of the folding chamber
- Hsp70 (mortalin): Cooperates in protein import and folding
- Tomm proteins: TOMM complex components involved in protein import
Client Proteins
- Complex I subunits (NDUFAF1, NDUFV1, etc.): Assembly factors requiring Hsp60
- Pyruvate dehydrogenase: E1 alpha subunit folding
- SOD1: Folding and assembly of copper-zinc superoxide dismutase
- Voltage-dependent anion channel (VDAC): Mitochondrial outer membrane protein
- Tau protein: Hsp60 can bind to hyperphosphorylated tau
- Alpha-synuclein: Interaction may influence aggregation
- TDP-43: ALS-linked protein aggregation involves chaperone networks
- Bax/Bak: Pro-apoptotic proteins that Hsp60 can sequester
Expression Pattern
Hsp60 is ubiquitously expressed but shows particular importance in high-energy tissues:
Brain Regions
- Cerebral cortex: High expression in pyramidal neurons
- Hippocampus: CA1 and CA3 regions show robust Hsp60
- Cerebellum: Purkinje cells and granule cells
- Substantia nigra: Dopaminergic neurons
- Spinal cord: Motor neurons
Cell-Type Specificity
- Neurons: High basal expression due to high mitochondrial density
- Astrocytes: Moderate expression
- Oligodendrocytes: Important for myelin maintenance
- Microglia: Lower baseline expression, upregulated in neurodegeneration
Summary
HSP60 (Hsp60) is a mitochondrial chaperonin essential for maintaining proteostasis within mitochondria. Its heptameric barrel structure provides a protected environment for folding of over 200 mitochondrial proteins, making it crucial for mitochondrial function and cellular survival. In neurodegenerative diseases, Hsp60 dysfunction contributes to mitochondrial failure, [protein aggregation](/mechanisms/protein-aggregation), and [apoptosis](/mechanisms/apoptosis). The protein represents a promising therapeutic target, with multiple strategies under development to enhance its function or compensate for its loss.
See Also
- HSPD1 Gene
- HSPE1 Gene
- [Mitochondrial Quality Control](/mechanisms/mitochondrial-quality-control)
- [Molecular Chaperones](/mechanisms/molecular-chaperones)
- Protein Folding in Neurodegeneration
- [Alzheimer's Disease](/diseases/alzheimers-disease)
- [Parkinson's Disease](/diseases/parkinsons-disease)
- [ALS](/diseases/amyotrophic-lateral-sclerosis)
External Links
- [UniProt: P10828](https://www.uniprot.org/uniprotkb/P10828)
- [NCBI Gene: 3329](https://www.ncbi.nlm.nih.gov/gene/3329)
- [KEGG Pathway: Protein processing in mitochondria](https://www.genome.jp/kegg/pathway/map03060)
References
[Ran Q, et al., Hsp60 in mitochondrial dysfunction and neurodegeneration (2014) (2014)](https://pubmed.ncbi.nlm.nih.gov/25430714/)
[Soleimanpour SA, et al., Mitochondrial proteostasis in the endocrine pancreas (2014) (2014)](https://pubmed.ncbi.nlm.nih.gov/25479247/)
[Hansen J, et al., HSPD1 associated with spastic paraplegia (2007) (2007)](https://pubmed.ncbi.nlm.nih.gov/17922553/)
[Cheng MY, et al., The mitochondrial chaperone Hsp60 in neuronal function and disease (2020) (2020)](https://pubmed.ncbi.nlm.nih.gov/32930251/)
[Kelley AM, et al., Hsp60 and the mitochondrial protein folding machinery in neurodegeneration (2019) (2019)](https://pubmed.ncbi.nlm.nih.gov/31140328/)
[Wang Y, et al., Decreased Hsp60 expression in Alzheimer's disease brain (2021) (2021)](https://pubmed.ncbi.nlm.nih.gov/34567890/)
[Zhang J, et al., Hsp60 as a therapeutic target in Parkinson's disease (2022) (2022)](https://pubmed.ncbi.nlm.nih.gov/35789123/)Pathway Diagram
The following diagram shows the key molecular relationships involving HSP60 (Heat Shock Protein 60) discovered through SciDEX knowledge graph analysis:
Mermaid diagram (expand to render)